• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自鼠疫耶尔森菌的重组荚膜抗原(1组分)可在BALB/c小鼠中诱导保护性抗体反应。

Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.

作者信息

Simpson W J, Thomas R E, Schwan T G

机构信息

National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, Hamilton, Montana.

出版信息

Am J Trop Med Hyg. 1990 Oct;43(4):389-96. doi: 10.4269/ajtmh.1990.43.389.

DOI:10.4269/ajtmh.1990.43.389
PMID:2240367
Abstract

Yersinia pestis produces a glycoprotein capsule, the biosynthesis of which appears to be temperature dependent. The fraction I (F1) component of this capsule is specific to Y. pestis and the detection of F1 antibodies is the basis for several serological tests. We report the cloning of the F1 gene and its expression in Escherichia coli using the phagemid vector lambda ZAPII and a F1-specific monoclonal antibody. The recombinant F1 antigen had a molecular weight of 17 kDa, which proved to be identical to that of the F1 antigen produced by Y. pestis. The recombinant cells produced F1 antigen at 37 degrees C but only minimal amounts at 27 degrees C, suggesting that the genetic features affected by temperature in Y. pestis may be operating in the E. coli clone. It is not known if their similar molecular weights reflect the glycosylated nature of both proteins. F1 antigen purified from the E. coli recombinant induced a protective immune response in BALB/c mice challenged with up to 10(5) virulent Y. pestis. The resistance of immunized mice to plague infection correlated with high titers of F1 antibody. The cloned gene expresses an immunogenically competent F1 antigen suitable for use in plague serodiagnostics and vaccine development.

摘要

鼠疫耶尔森菌产生一种糖蛋白荚膜,其生物合成似乎依赖于温度。该荚膜的I组分(F1)是鼠疫耶尔森菌特有的,F1抗体的检测是几种血清学检测的基础。我们报道了利用噬菌粒载体λZAPII和F1特异性单克隆抗体克隆F1基因并在大肠杆菌中表达。重组F1抗原的分子量为17 kDa,与鼠疫耶尔森菌产生的F1抗原相同。重组细胞在37℃时产生F1抗原,但在27℃时仅产生极少量,这表明鼠疫耶尔森菌中受温度影响的遗传特性可能在大肠杆菌克隆中起作用。尚不清楚它们相似的分子量是否反映了两种蛋白质的糖基化性质。从大肠杆菌重组体中纯化的F1抗原在用高达10^5毒力的鼠疫耶尔森菌攻击的BALB/c小鼠中诱导了保护性免疫反应。免疫小鼠对鼠疫感染的抵抗力与高滴度的F1抗体相关。克隆的基因表达了一种免疫原性活性的F1抗原,适用于鼠疫血清诊断和疫苗开发。

相似文献

1
Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.来自鼠疫耶尔森菌的重组荚膜抗原(1组分)可在BALB/c小鼠中诱导保护性抗体反应。
Am J Trop Med Hyg. 1990 Oct;43(4):389-96. doi: 10.4269/ajtmh.1990.43.389.
2
Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.腺病毒衣壳中包含 V 抗原或 F1 荚膜抗原诱导的针对致死性呼吸道鼠疫耶尔森菌感染的保护性免疫。
Hum Gene Ther. 2010 Jul;21(7):891-901. doi: 10.1089/hum.2009.148.
3
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.一种多抗原蛋白融合疫苗候选物的研制,能预防炭疽杆菌和鼠疫耶尔森菌。
PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007644. doi: 10.1371/journal.pntd.0007644. eCollection 2019 Aug.
4
Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.利用新型递送载体,开发使用B细胞和T细胞表位及其源自鼠疫耶尔森氏菌F1抗原构建体的亚单位免疫原。
FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):215-29. doi: 10.1016/S0928-8244(03)00170-6.
5
Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.鼠疫耶尔森氏菌荚膜F1-V抗原单体及修饰融合蛋白的纯化及其用于鼠疫疫苗接种的保护效力
Protein Expr Purif. 2007 May;53(1):63-79. doi: 10.1016/j.pep.2006.12.018. Epub 2006 Dec 31.
6
Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.用重组鼠疫抗原进行同源和异源初免-加强免疫后对气溶胶化鼠疫耶尔森菌攻击的保护作用。
Infect Immun. 2005 Aug;73(8):5256-61. doi: 10.1128/IAI.73.8.5256-5261.2005.
7
Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.鼠伤寒沙门氏菌aroA突变体表面表达鼠疫耶尔森氏菌荚膜抗原(F1抗原)可诱导产生高水平的鼠疫防护力。
Infect Immun. 1997 May;65(5):1926-30. doi: 10.1128/iai.65.5.1926-1930.1997.
8
Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.F1/V融合蛋白在减毒鼠伤寒沙门氏菌中的表达及对小鼠的鼠疫保护作用。
Microb Pathog. 1997 Sep;23(3):167-79. doi: 10.1006/mpat.1997.0141.
9
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.重组V抗原可保护小鼠免受由鼠疫耶尔森氏菌F1荚膜阳性和阴性菌株引起的肺鼠疫和腺鼠疫。
Infect Immun. 1996 Nov;64(11):4580-5. doi: 10.1128/iai.64.11.4580-4585.1996.
10
Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.经胃内给予鼠疫耶尔森菌荚膜抗原未能保护小鼠免受强毒鼠疫的攻击:对1组分特异性抗体反应的抑制。
Am J Trop Med Hyg. 1992 Jul;47(1):92-7. doi: 10.4269/ajtmh.1992.47.92.

引用本文的文献

1
Nanolipoprotein particle (NLP) vaccine confers protection against aerosol challenge in a BALB/c mouse model.纳米脂蛋白颗粒(NLP)疫苗在BALB/c小鼠模型中可提供针对气溶胶攻击的保护作用。
Front Immunol. 2025 Jun 26;16:1603710. doi: 10.3389/fimmu.2025.1603710. eCollection 2025.
2
Evidence of a role for the F1 capsule of in enhancing transmission from mammals to fleas in a mouse model of bubonic plague.在腺鼠疫小鼠模型中,关于F1荚膜在增强从哺乳动物传播至跳蚤过程中作用的证据。
mBio. 2025 May 14;16(5):e0030125. doi: 10.1128/mbio.00301-25. Epub 2025 Mar 26.
3
Plague Prevention and Therapy: Perspectives on Current and Future Strategies.
鼠疫的预防与治疗:当前及未来策略展望
Biomedicines. 2021 Oct 9;9(10):1421. doi: 10.3390/biomedicines9101421.
4
The Use of an Organo-Selenium Peptide to Develop New Antimicrobials That Target a Specific Bacteria.利用一种有机硒肽开发针对特定细菌的新型抗菌剂。
Antibiotics (Basel). 2021 May 21;10(6):611. doi: 10.3390/antibiotics10060611.
5
Plague vaccine: recent progress and prospects.鼠疫疫苗:近期进展与前景
NPJ Vaccines. 2019 Feb 18;4:11. doi: 10.1038/s41541-019-0105-9. eCollection 2019.
6
Plague Vaccines: Status and Future.鼠疫疫苗:现状与未来
Adv Exp Med Biol. 2016;918:313-360. doi: 10.1007/978-94-024-0890-4_12.
7
LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.通过减毒活鼠疫耶尔森氏菌的III型分泌系统递送的LcrV增强了针对肺鼠疫的免疫原性。
Infect Immun. 2014 Oct;82(10):4390-404. doi: 10.1128/IAI.02173-14. Epub 2014 Aug 11.
8
A Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challenge.鼠疫耶尔森菌tat突变体在腺鼠疫和小剂量气溶胶吸入性肺炎感染攻击模型中减毒,但经鼻内攻击时减毒程度较小。
PLoS One. 2014 Aug 7;9(8):e104524. doi: 10.1371/journal.pone.0104524. eCollection 2014.
9
Omics strategies for revealing Yersinia pestis virulence.基于组学的方法揭示鼠疫耶尔森氏菌毒力。
Front Cell Infect Microbiol. 2012 Dec 13;2:157. doi: 10.3389/fcimb.2012.00157. eCollection 2012.
10
Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.将鼠疫耶尔森氏菌 F1 抗原与金纳米颗粒结合可提高免疫原性。
Vaccine. 2012 Nov 6;30(48):6777-82. doi: 10.1016/j.vaccine.2012.09.021. Epub 2012 Sep 18.